title: Evolving molecular classification by genomic and proteomic biomarkers in colorectal cancer: potential implications for the surgical oncologist.
abstract: Colorectal cancer (CRC) is one of the most frequent cancers in the Western world and represents a major health burden. CRC development is a multi-step process that spans 10-15years, thereby providing an opportunity for early detection and even prevention. As almost half of all patients undergoing surgery develop recurrent disease, surveillance is advocated, albeit with various means and intervals. Current screening and surveillance efforts have so far only had limited impact due to suboptimal compliance. Currently, CEA is the only biomarker in clinical use for CRC, but has suboptimal sensitivity and specificity. New and better biomarkers are therefore strongly needed. Non-invasive biomarkers may develop through the understanding of colorectal carcinogenesis. Three main pathways occur in CRC, including chromosomal instability (CIN), microsatellite instability (MSI) and epigenetic silencing through the CpG Island Methylator Phenotype (CIMP). These pathways have distinct clinical, pathological, and genetic characteristics, which can be used for molecular classification and comprehensive tumour profiling for improved diagnostics, prognosis and treatment in CRC. Molecular-biological research has advanced with the sequencing of the human genome and the availability of genomic and proteomic high-throughput technologies using different chip platforms, such as tissue microarrays, DNA microarrays, and mass spectrometry. This review aims to give an overview of the evolving biomarker concepts in CRC, with concerns on methods, and potential for clinical implications for the surgical oncologist.
authors.affiliation: Department of General & Gastroenterologic Surgery, Stavanger University Hospital, P.O. Box 8100, N-4068 Stavanger, Norway. ksoreide@mac.com
authors.forename: Kjetil
authors.initials: K
authors.lastname: Søreide
authors.forename: Bjørn S
authors.initials: BS
authors.lastname: Nedrebø
authors.forename: Jens-Christian
authors.initials: JC
authors.lastname: Knapp
authors.forename: Tom B
authors.initials: TB
authors.lastname: Glomsaker
authors.forename: Jon Arne
authors.initials: JA
authors.lastname: Søreide
authors.forename: Hartwig
authors.initials: H
authors.lastname: Kørner
mesh_terms: D014408:Biomarkers, Tumor / Q000235:genetics* / Q000378:metabolism*; D015179:Colorectal Neoplasms / Q000145:classification* / Q000175:diagnosis* / Q000601:surgery; D023281:Genomics; D006801:Humans; D008495:Medical Oncology; D010819:Physician's Role; D040901:Proteomics
chemical_list: D014408:Biomarkers, Tumor